Exploring the link between psychological distress and treatment outcomes in lung cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how psychological distress affects the efficacy and survival of anti-tumor therapies, including immunotherapy and targeted therapy, in patients with advanced lung cancer. It aims to understand the multi-faceted nature of psychological distress and its impact on coping with cancer and treatment. By analyzing the associations between psychological stress and treatment outcomes, the study seeks to identify potential ways to improve patient care and therapeutic effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Histologically proven diagnosis of lung cancer
* 18 years of age or older
* Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* Not willing to participate in this clinical trial

Where it's running

• Shanghai Chest Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Xiaomin Niu
• Email: ar_tey@hotmail.com
• Phone: (86) 21 22200000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Multi-omics blood and CT monitoring for early detection of lung cancer recurrence after neoadjuvant therapy and surgery

  This project tests whether combining blood-based multi-omics (metabolomics and cfDNA), CT radiomics, and AI can noninvasively detect early recurrence after surgery in NSCLC patients treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07291921

• Assessing cognitive and quality of life issues in advanced cancer survivors treated with immunotherapy

  This study is testing a new therapy to see if it can help advanced cancer survivors who have received immunotherapy improve their mental health and cognitive challenges.

  Recruiting at 2 sites Universitair Ziekenhuis Brussel · Brussels, Brussels Capital and 1 other locations · NCT05667857

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• PULSAR radiotherapy plus immunotherapy for high-risk advanced liver cancer

  This study tests whether adding PULSAR radiotherapy to standard immunotherapy helps adults with high‑risk advanced liver cancer live longer without their cancer progressing.

  Recruiting Phase 2 Samsung Medical Center · Seoul · NCT07884877

• Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation

  A online program tests a self-guided mindfulness app for distressed parents going through divorce or separation, to see if it helps parent and child wellbeing.

  Recruiting University of Connecticut · Stamford, Connecticut · NCT07871916

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.